Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108660122A details high-efficiency transaminase mutant for L-glufosinate-ammonium production offering significant supply chain and cost advantages for global agrochemical manufacturers.
Patent CN104402814A details a one-pot synthesis reducing waste. We offer high-purity agrochemical intermediates with scalable, cost-effective manufacturing solutions.
Patent CN105367535B reveals trisulfonic acid ionic liquid catalyst for high-purity acridine derivatives manufacturing with reduced waste and cost.
Patent CN116102406B introduces tunable biphenol ligands enhancing enantioselectivity. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing processes.
Patent CN107384885B reveals enzymatic synthesis of chiral amines. Achieve cost reduction in API manufacturing with high conversion and optical purity.
Patent CN101974604A reveals a green enzymatic route for paroxetine intermediates using ionic liquids, offering high purity and reduced environmental impact for API manufacturing.
Patent CN1968927B details a novel Ru-catalyzed route for high-purity quinoline intermediates used in bronchodilators, offering significant cost reduction in API manufacturing.
Patent CN110835639A reveals a dual-enzyme DKR process for high-purity (S)-tetrahydroisoquinoline derivatives, offering superior ee values and scalable manufacturing for pharmaceutical intermediates.
Patent CN109182410B details a high-yield biocatalytic route for chiral piperidine intermediates, offering significant cost reduction in API manufacturing and superior supply chain reliability.
Patent CN109852593B details a high-activity CmCR mutant for R-3HB production, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113174377A reveals stable carbonyl reductase mutants for high-yield diltiazem intermediate synthesis, offering cost-effective biocatalysis solutions.
Patent CN102199146A details a high-yield catalytic transfer hydrogenation for Imatinib intermediates, offering superior purity and supply chain reliability for global pharmaceutical manufacturers.
Novel patent CN105693737A describes efficient synthesis of chiral ligands. Offers supply chain stability and cost reduction for pharmaceutical manufacturing partners globally.
Patent CN113024493A reveals ammonium chloride catalysis for 3A5AF. Cost-effective biomass route for pharma intermediates.
Patent CN102432628A reveals a one-pot synthesis for Cefonicid intermediate BP1, eliminating boric acid filtration and boosting yield to 99%.
Patent CN110317849B reveals a high-yield enzymatic method for producing chiral tetrahydroisoquinoline intermediates, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN114736882A discloses high-performance monoamine oxidase mutants for asymmetric oxidation, enabling cost reduction in API manufacturing and reliable supply.
Patent CN110835639B reveals a high-efficiency enzymatic route for producing chiral tetrahydroisoquinoline intermediates with superior stereoselectivity and scalable manufacturing potential.
Novel dehalogenase method for pitavastatin intermediates offers high purity and yield. Reduces environmental impact and enhances supply chain reliability for pharmaceutical manufacturers globally.
Patent CN104341294B reveals a novel catalytic route for high-purity methyl 4-methoxyvalerate. Discover cost-effective biomass conversion and scalable supply chain solutions.